Cyclic dinucleotides and the innate immune response
- PMID: 23993090
- PMCID: PMC3931520
- DOI: 10.1016/j.cell.2013.08.014
Cyclic dinucleotides and the innate immune response
Abstract
Cyclic dinucleotides (CDNs) have been previously recognized as important secondary signaling molecules in bacteria and, more recently, in mammalian cells. In the former case, they represent secondary messengers affecting numerous responses of the prokaryotic cell, whereas in the latter, they act as agonists of the innate immune response. Remarkable new discoveries have linked these two patterns of utilization of CDNs as secondary messengers and have revealed unexpected influences they likely had on shaping human genetic variation. This Review summarizes these recent insights and provides a perspective on future unanswered questions in this exciting field.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
References
-
- Antonelli LR, Gigliotti Rothfuchs A, Gonçalves R, Roffê E, Cheever AW, Bafica A, Salazar AM, Feng CG, Sher A. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest. 2010;120:1674–1682. - PMC - PubMed
-
- Barber GN. Cytoplasmic DNA innate immune pathways. Immunol Rev. 2011a;243:99–108. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
